Berkeley Lights Announces Opto™ Antigen-Presenting Bead Kit to Accelerate the Expansion of Antigen-Specific T Cells Used to Develop Cell-Based Therapies

EMERYVILLE, Calif. — Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the Opto Antigen-Presenting Bead (APB) kit, a new reagent kit that activates and expands antigen-specific T cells in peripheral blood to create artificial T cells. The APB kit is ten times more effective than the current, standard dendritic cell process, which [...]

Certara Launches Version 8.3 of Phoenix™ Biosimulation Software for Drug Development

Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J. Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and quality and save [...]

Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis

Partnership targets accelerating the commercialization of enzymatic DNA synthesis; Codexis invests cash and protein engineering for equity stake in Molecular Assemblies REDWOOD CITY, Calif. and SAN DIEGO  – Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce [...]

PathGroup Selected as Early Access Partner for Launch of Illumina’s Sequencing-Based COVID-19 Diagnostic Test

First-of-its-kind test allows for significant increase in testing capacity NASHVILLE, Tenn. - PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, today announced the company has been selected as an early access partner for the launch of Illumina's new sequencing-based COVID-19 test, COVIDSeq. COVIDSeq accommodates more [...]

Kerafast Offers the Delta-G-VSV Pseudotyping System for Coronavirus Research

Reverse genetics system enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness Boston, MA. -- Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by the Michael Whitt laboratory at University of Tennessee, enables [...]

Galenvs Announces an Agreement with The Government of Canada to Provide Reagents Required for COVID-19 Testing

MONTREAL - Montreal-based biotechnology provider Galenvs Sciences Inc. "Galenvs", today announces that the Canadian Federal Government has signed an agreement with Galenvs to supply functionalized magnetic reagents for Coronavirus RNA extraction necessary to enable the COVID-19 testing efforts across Canada. Galenvs is producing magnetic-based reagents specifically designed for Coronavirus RNA extraction methodologies used in all federal research institutions. [...]

DKSH extends partnership with Bruker in China

DKSH and Bruker have extended their distribution agreement in China to expand coverage for Bruker’s 3D X-ray Microscopy product portfolio for non-destructive imaging technology. Shanghai, China – DKSH Business Unit Technology and Bruker, renowned for its market leading analytical X-ray solutions, have extended their distribution agreement in China. Last year in April, the two companies [...]

IDT launches gBlocks™ HiFi, improving on industry-leading products for synthetic biology

Quality and Fidelity: New double-stranded DNA fragments are ideal for accelerating research across applications and disciplines CORALVILLE, Iowa  – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced the launch of gBlocks™ HiFi Gene Fragments. The industry-leading quality of these double-stranded DNA fragments make them an ideal solution for everything from traditional cloning to the [...]

Waters Introduces the New Arc High-Performance Liquid Chromatograph to Help Laboratories Meet Quality and Production Targets

Modern LC System Replicates Established Test Methods, Delivers Improved Performance; Updates to Lab Business Continuity Solution Also Announced   MILFORD, Mass.--Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ HPLC System, a new high-performance liquid chromatograph (HPLC) for routine testing in the pharmaceutical, food, academic and materials markets. A key target application is quality control laboratories performing [...]

Waters Extends the Capability and Power of its High-Resolution Mass Spectrometers

Enhancements for the Waters Xevo G2-XS QTof, SYNAPT XS and SELECT SERIES Cyclic IMS Instruments Accelerate Biomedical and Pharmaceutical Research   ILFORD, Mass.-- Waters Corporation (NYSE:WAT) announced today a new fragmentation technique and an imaging option for its high-resolution mass spectrometers giving research scientists working across a broad range of end markets including biomedical, biopharmaceutical and [...]

Access IBO on Knowledge Center